MYO - Myomo Inc Stock Price, Fair Value and News

$6.18+0.09 (+1.48%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

MYO Price Action

Last 7 days

-1.3%

Last 30 days

25.6%

Last 90 days

58.9%

Trailing 12 Months

43.1%

MYO RSI Chart

MYO Valuation

Market Cap

186.9M

Price/Earnings (Trailing)

-22.3

Price/Sales (Trailing)

7.41

EV/EBITDA

-22.85

Price/Free Cashflow

-19.59

MYO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MYO Fundamentals

MYO Revenue

Revenue (TTM)

25.2M

Rev. Growth (Yr)

81.27%

Rev. Growth (Qtr)

22.43%

MYO Earnings

Earnings (TTM)

-8.4M

Earnings Growth (Yr)

52.37%

Earnings Growth (Qtr)

13.84%

MYO Profitability

Operating Margin

70.03%

EBT Margin

-31.82%

Return on Equity

-90.22%

Return on Assets

-51.39%

Free Cashflow Yield

-5.11%

MYO Investor Care

Shares Dilution (1Y)

14.07%

Diluted EPS (TTM)

-0.23

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	19.5M	21.1M	25.2M	0
2023	15.1M	17.4M	18.5M	19.2M
2022	15.4M	16.0M	15.5M	15.6M
2021	8.9M	11.2M	13.6M	13.9M
2020	4.0M	4.0M	5.3M	7.6M
2019	3.0M	3.2M	3.2M	3.8M
2018	1.7M	2.0M	2.1M	2.4M
2017	1.2M	1.3M	1.4M	1.6M
2016	0	0	0	1.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

CEO	Mr. Paul R. Gudonis
WEBSITE	https://myomo.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	100

Myomo Inc Frequently Asked Questions

What is the ticker symbol for Myomo Inc? What does MYO stand for in stocks?

MYO is the stock ticker symbol of Myomo Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Myomo Inc (MYO)?

As of Fri Dec 20 2024, market cap of Myomo Inc is 186.92 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MYO stock?

You can check MYO's fair value in chart for subscribers.

Is Myomo Inc a good stock to buy?

The fair value guage provides a quick view whether MYO is over valued or under valued. Whether Myomo Inc is cheap or expensive depends on the assumptions which impact Myomo Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MYO.

What is Myomo Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, MYO's PE ratio (Price to Earnings) is -22.3 and Price to Sales (PS) ratio is 7.41. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MYO PE ratio will change depending on the future growth rate expectations of investors.